$51.14
+0.43%
N/A+$0.22
Healthcare
Drug Manufacturers - General
OTC
Active Trading
Roche Holding AG functions as a major global healthcare enterprise, primarily concentrating its efforts within the pharmaceutical and diagnostic sectors. The company ...
Financial highlights
Latest / TTM · 6 periods
Snapshot
Latest / TTM: 2026-07-22
Gross Margin
—
Net Margin
—
P/E Ratio
—
Debt / Equity
—
Profitability
Profitability table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Gross MarginGross profit as a percentage of revenue. | 68.6% | 72.7% | 74.2% | 73.9% | 73.7% | — |
| Operating MarginOperating income as a percentage of revenue. | 27.5% | 26.6% | 25.5% | 21.5% | 29.2% | — |
| Net MarginNet income as a percentage of revenue. | 22.2% | 18.9% | 19.0% | 13.3% | 20.3% | — |
| EBITDA MarginEBITDA divided by revenue. | 35.3% | 36.6% | 30.5% | 26.6% | 34.3% | — |
| Pre-tax MarginPre-tax profit as a percentage of revenue. | 27.7% | 24.9% | 23.3% | 18.9% | 26.8% | — |
Liquidity & leverage
Liquidity & leverage table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Current RatioCurrent assets divided by current liabilities. | 0.93 | 1.24 | 1.35 | 1.48 | 1.38 | — |
| Quick RatioLiquid assets divided by current liabilities. | 0.73 | 0.93 | 1.04 | 1.20 | 1.12 | — |
| Cash RatioCash and equivalents divided by current liabilities. | 0.18 | 0.18 | 0.22 | 0.26 | 0.20 | — |
| Debt / AssetsDebt as a share of total assets. | 35.3% | 30.1% | 34.0% | 35.7% | 32.9% | — |
| Debt / EquityDebt compared with shareholder equity. | 1.33 | 0.95 | 1.05 | 1.14 | 0.98 | — |
Operating efficiency
Operating efficiency table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Receivables TurnoverHow often receivables are collected in a year. | 4.96x | 4.75x | 4.66x | 4.62x | 5.32x | — |
| Inventory TurnoverHow often inventory is sold in a year. | 2.55x | 2.08x | 2.01x | 2.14x | 2.22x | — |
| Payables TurnoverHow often payables are paid in a year. | 5.13x | 4.65x | 4.43x | 4.09x | 2.88x | — |
| Asset TurnoverRevenue generated per dollar of assets. | 0.68x | 0.75x | 0.67x | 0.61x | 0.63x | — |
| Working Capital TurnoverRevenue generated per dollar of working capital. | 26.43x | 34.75x | 7.95x | 5.77x | 5.33x | — |
Valuation ratios
Valuation ratios table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| P/E RatioPrice paid for each dollar of earnings. | 23.00x | 18.64x | 16.93x | 24.38x | 20.25x | — |
| P/B RatioPrice paid for each dollar of book value. | 13.09x | 8.27x | 6.64x | 6.35x | 7.76x | — |
| P/S RatioPrice paid for each dollar of sales. | 5.10x | 3.52x | 3.22x | 3.24x | 4.15x | — |
| P/FCF RatioPrice paid for each dollar of free cash flow. | 20.00x | 17.36x | 17.01x | 13.38x | 19.53x | — |
| Dividend YieldAnnual dividend divided by current share price. | 2.4% | 3.2% | 3.9% | 3.8% | 3.0% | — |